These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21270096)

  • 1. Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone.
    Wesson DE; Simoni J; Broglio K; Sheather S
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F830-7. PubMed ID: 21270096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet.
    Wesson DE; Simoni J
    Kidney Int; 2010 Dec; 78(11):1128-35. PubMed ID: 20861823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II-mediated GFR decline in subtotal nephrectomy is due to acid retention associated with reduced GFR.
    Wesson DE; Jo CH; Simoni J
    Nephrol Dial Transplant; 2015 May; 30(5):762-70. PubMed ID: 25527741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptors mediate increased distal nephron acidification caused by acid retention.
    Wesson DE; Jo CH; Simoni J
    Kidney Int; 2012 Dec; 82(11):1184-94. PubMed ID: 22832514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid retention in chronic kidney disease is inversely related to GFR.
    Goraya N; Simoni J; Sager LN; Pruszynski J; Wesson DE
    Am J Physiol Renal Physiol; 2018 May; 314(5):F985-F991. PubMed ID: 29357423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
    Goraya N; Simoni J; Sager LN; Madias NE; Wesson DE
    Kidney Int; 2019 May; 95(5):1190-1196. PubMed ID: 30846270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing acid retention.
    Ring T
    Am J Physiol Renal Physiol; 2011 Nov; 301(5):F1139; author reply F1140-2. PubMed ID: 22042789
    [No Abstract]   [Full Text] [Related]  

  • 10. Does correction of metabolic acidosis slow chronic kidney disease progression?
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):193-7. PubMed ID: 23380803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid-base status and progression of chronic kidney disease.
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2012 Sep; 21(5):552-6. PubMed ID: 22874469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors.
    Phisitkul S; Hacker C; Simoni J; Tran RM; Wesson DE
    Kidney Int; 2008 Jan; 73(2):192-9. PubMed ID: 17978813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential benefits of alkali therapy to prevent GFR loss: time for a palatable 'solution' for the management of CKD.
    Sahni V; Rosa RM; Batlle D
    Kidney Int; 2010 Dec; 78(11):1065-7. PubMed ID: 21076447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.
    Lorenzen J; Krämer R; Kliem V; Bode-Boeger SM; Veldink H; Haller H; Fliser D; Kielstein JT
    Eur J Clin Invest; 2010 Apr; 40(4):294-300. PubMed ID: 20486990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
    Imai E; Horio M; Yamagata K; Iseki K; Hara S; Ura N; Kiyohara Y; Makino H; Hishida A; Matsuo S
    Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced plasma endothelin in healthy uninephrectomized subjects during basal conditions and after indomethacin.
    Nielsen CB; Sørensen SS; Pedersen EB
    Nephrol Dial Transplant; 1994; 9(1):5-9. PubMed ID: 8177477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.